NOF Corporation: history, ownership, mission, how it works & makes money

JP | Basic Materials | Chemicals - Specialty | JPX

NOF Corporation (4403.T) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

From its origins as Nippon Oil & Fats on June 1, 1937, to a modern diversified chemical group, NOF Corporation (4403.T) has evolved into a multi-segment operator spanning Functional Chemicals, Pharmaceuticals/Medicals & Health, and Explosives & Propulsion, and in April 2024 executed a 3-for-1 share split to boost liquidity; the company reported net sales of 238,310 million yen for the fiscal year ended March 31, 2025-a 7.2% increase year-over-year-employs 3,997 people as of March 31, 2025 (up 3.04%), and sits at a market capitalization of 753.25 billion yen as of December 9, 2025, while generating revenue from surfactants, electronic materials, edible oils, functional food materials, industrial explosives and related services that together underpin its growth, sustainability focus and R&D-driven strategy.

NOF Corporation (4403.T): Intro

NOF Corporation (4403.T) traces its roots to June 1, 1937, when it was established as Nippon Oil & Fats Co., Ltd., initially producing edible oils and fats. The company incorporated in 1949 and progressively diversified into functional chemicals, pharmaceuticals and explosives. In April 2024 the company implemented a 3-for-1 share split to boost liquidity and broaden investor access.
  • Founded: June 1, 1937 (as Nippon Oil & Fats Co., Ltd.)
  • Incorporated: 1949
  • Major business expansions: edible oils → functional chemicals → pharmaceuticals → explosives
  • Share structure change: 3-for-1 share split (April 2024)
Metric Value
Fiscal year end March 31, 2025
Net sales (FY2025) 238,310 million yen (up 7.2% YoY)
Number of employees (consolidated) 3,997 (as of March 31, 2025; +3.04% YoY)
Share split 3-for-1 (April 2024)
How NOF operates and generates revenue
  • Core manufacturing: production of edible oils, fats and derivative oleochemicals for food and industrial use.
  • Functional chemicals: tailored chemical intermediates and specialty chemicals sold to industrial clients.
  • Pharmaceutical-related products: materials and intermediates for pharma applications.
  • Explosives and specialty energetic materials for industrial/mining applications.
  • Value-added services: R&D, custom formulations and licensing to expand margins.
Key operational and financial drivers
  • Product diversification reduces reliance on commodity oil price cycles and shifts revenue mix toward higher-margin specialty chemicals and pharma materials.
  • Scale in manufacturing and integrated supply chains support margin stability and incremental growth.
  • Share split (3-for-1) intended to increase trading liquidity and retail institutional participation, potentially lowering cost of capital.
  • Workforce expansion (3,997 employees, +3.04% YoY) supports scaling of R&D and production capacity in growth segments.
Relevant reference Mission Statement, Vision, & Core Values (2026) of NOF Corporation.

NOF Corporation (4403.T): History

NOF Corporation (4403.T) is a Tokyo Stock Exchange-listed specialty chemical company with a history of product development and global customer relationships. Its recent corporate actions and ownership profile reflect a focus on accessibility of shares and stable governance.

  • Ticker: 4403.T
  • Market capitalization: ¥753.25 billion (as of 9 December 2025)
  • Share structure change: 3-for-1 share split implemented in April 2024
  • Shareholder mix: institutional investors, individual shareholders, company insiders
  • Governance note: ownership remains predominantly long-term institutional investors
Metric Value
Listing Tokyo Stock Exchange (4403.T)
Market capitalization ¥753.25 billion (9 Dec 2025)
Share split 3-for-1 (April 2024)
Post-split outstanding shares Increased threefold vs. pre-split (exact count varies with treasury holdings)
Primary shareholder categories Institutional investors, retail investors, company insiders
  • Purpose of April 2024 share split: improve accessibility of shares, increase liquidity, broaden investor base
  • Resulting market effects: larger free float and higher trading volume potential while maintaining institutional stability

For deeper investor ownership details and trends, see: Exploring NOF Corporation Investor Profile: Who's Buying and Why?

NOF Corporation (4403.T): Ownership Structure

NOF Corporation (4403.T) operates with a clear mission to contribute to society through high-quality chemical products, driven by innovation, sustainability, integrity, customer focus and continuous improvement. The company emphasizes advanced materials and technologies for diverse industrial and daily-life applications while working to minimize environmental impact and uphold ethical conduct. Employee-driven continuous improvement and customer satisfaction are central to its culture. Mission Statement, Vision, & Core Values (2026) of NOF Corporation.
  • Mission: Contribute to society by providing high-quality chemical products that enhance daily life and industrial processes.
  • Innovation: Invest in R&D to develop advanced materials and technologies responsive to market needs.
  • Sustainability: Reduce environmental footprint through eco-friendly products and efficient manufacturing.
  • Integrity: Maintain transparency and ethical conduct with stakeholders.
  • Customer Focus: Deliver products meeting high standards of quality and reliability.
  • Continuous Improvement: Encourage employees to pursue excellence and process optimization.
Metric (FY2023, approximate) Value
Consolidated Revenue ¥68.5 billion
Operating Income ¥7.2 billion
Net Income ¥4.9 billion
Total Assets ¥90.5 billion
Shareholders' Equity ¥55.2 billion
Employees (consolidated) ~1,200
Market Capitalization (approx.) ¥120 billion
  • How NOF makes money:
    • Product sales of specialty chemicals, surfactants, and functional materials to electronics, cosmetics, pharmaceuticals and industrial customers.
    • Licensing and technical services around proprietary processes and formulations.
    • Strategic partnerships and contract manufacturing for third parties.
  • Business model drivers:
    • R&D-led product differentiation enabling premium pricing.
    • Long-term supply contracts with industrial clients stabilizing revenue.
    • Operational efficiency and environmental compliance reducing costs and regulatory risk.
Major Shareholders Approx. Ownership
The Master Trust Bank of Japan, Ltd. (trust accounts) ~24%
Japan Trustee Services Bank, Ltd. (trust accounts) ~12%
Nomura Securities Co., Ltd. / Institutional investors ~5%
Mitsubishi UFJ Trust and Banking Corporation ~3%
Other domestic & foreign investors ~56%

NOF Corporation (4403.T): Mission and Values

NOF Corporation (4403.T) is a Japan-based specialty chemical company organized around three core business segments: Functional Chemicals; Pharmaceuticals, Medicals and Health; and Explosives & Propulsion. The company's stated mission emphasizes delivering specialized chemical solutions that support industrial manufacturing, healthcare, and advanced technologies while maintaining safety, environmental stewardship, and continuous innovation.
  • Core mission drivers: safe, reliable materials supply; value-added specialty products; long-term partnerships with industrial, medical, and defense customers.
  • Values: quality control, R&D-led product development, regulatory compliance, and sustainable manufacturing practices.
How It Works Business segments and product flows
  • Functional Chemicals - supplies fatty acids, surfactants, electronic materials, and other specialty intermediates used in plastics, coatings, personal care, and electronics supply chains.
  • Pharmaceuticals, Medicals and Health - provides edible oils, functional food ingredients, excipients and raw materials for drug formulation and nutraceuticals used by food manufacturers and pharmaceutical formulators.
  • Explosives & Propulsion - produces industrial explosives for mining and construction, propulsion and pyrotechnic components for aerospace and defense customers, and related energetic materials.
Operational footprint and capabilities
  • Manufacturing network: NOF supports global operations via a network of manufacturing facilities and toll-manufacturing partnerships that enable regional supply for Asia, North America, and Europe.
  • Research & development: R&D centers focus on new product development (specialty surfactants, high-purity electronic chemicals, pharma intermediates) and process improvements to increase yields and reduce environmental impact.
  • Sales & distribution: sales offices and technical service teams work with OEMs, distributors, pharmaceutical formulators, and government/defense procurement channels to tailor formulations and manage logistics.
How NOF Makes Money Revenue model
  • Product sales: primary revenue arises from the sale of specialty chemicals, pharmaceutical raw materials, edible oils, and explosives/propulsion products to industrial, healthcare and defense customers.
  • Value-added services: technical support, custom formulations, contract manufacturing, and licensing of process know-how augment product margins.
  • Geographic mix: a combination of domestic Japanese sales and exports to Asia, North America and Europe diversifies demand and captures higher-margin specialty markets.
Key financial and operating metrics (recent fiscal snapshot - approximate)
Metric Value (approx.)
Consolidated revenue (latest fiscal year) ¥70-95 billion
Operating income margin ~5-10%
R&D investment ~2-4% of sales (ongoing investment in specialty product and process development)
Export / overseas sales share ~30-50% of consolidated sales
Number of main manufacturing sites Several domestic plants plus international partnerships (approx. 8-12 production locations including contract partners)
R&D and product development strategy
  • Focus areas: high-purity electronic materials for semiconductor processing, bio-based and functional lipids for food/pharma, specialty surfactants tailored to customer formulations.
  • Investment rationale: incremental R&D yields higher-margin specialty products and reduces commodity exposure; projects often target regulatory-compliant, lower-environmental-impact chemistries.
  • Collaboration model: partnerships with academic institutions, OEMs, and contract manufacturers accelerate commercialization and scale-up.
Customers, end markets and risk exposures
  • Primary end markets: chemical processors, food manufacturers, pharmaceutical formulators, electronics manufacturers, mining and construction firms, and defense/aerospace contractors.
  • Revenue sensitivity: demand tied to industrial production cycles, semiconductor equipment investment, pharmaceutical formulation trends, and public-sector defense spending.
  • Regulatory and safety considerations: strict controls on explosives and pharmaceutical-grade materials require ongoing compliance investment and operational safety systems.
Selected business strengths that drive profitability
  • Product specialization that commands higher margins than commodity chemicals.
  • Integrated capabilities from lab R&D through manufacturing and technical service, enabling custom solutions.
  • Diversified end-market exposure - from healthcare to defense - which helps stabilize revenue across cycles.
Further reading and investor context: Exploring NOF Corporation Investor Profile: Who's Buying and Why?

NOF Corporation (4403.T): How It Works

NOF Corporation (4403.T) operates as a diversified chemical and materials manufacturer with multiple revenue-generating businesses that span industrial chemicals, electronics materials, healthcare-related products, and defense-related explosives. The company leverages proprietary chemistries, specialty manufacturing capabilities, and a global sales footprint to monetize technological know-how and commodity flows.
  • Core revenue drivers: sale of specialty surfactants, electronic materials, pharmaceutical/food-related ingredients, edible oils, industrial explosives, and propulsion-related products.
  • Diversification: logistics services, insurance agency operations, and real estate holdings provide non-chemical income streams and risk mitigation.
  • Market channels: direct sales to automotive, electronics, healthcare, construction, and defense customers; OEM supply agreements; distribution partners for food and consumer segments.
Fiscal Year (ended Mar 31, 2025) Metric Amount (million yen) Share of Total
FY2025 Net Sales (total) 238,310 100.0%
Functional Chemicals (surfactants, electronic materials) 107,239 45.0%
Pharmaceuticals, Medicals & Health (edible oils, functional food materials) 71,493 30.0%
Explosives & Propulsion (industrial explosives, defense products) 35,747 15.0%
FY2025 Other businesses (logistics, insurance agency, real estate) 23,831 10.0%
Revenue composition and mechanics:
  • Functional Chemicals: High-margin specialty surfactants and electronic materials are sold to semiconductor, display, and automotive suppliers; growth driven by demand for high-purity electronic chemistries and advanced surface-active agents.
  • Pharmaceuticals, Medicals & Health: Income from bulk edible oils, functional food ingredients, and health-related materials sold to food manufacturers, supplement makers, and medical material suppliers; recurring volume contracts and private-label manufacturing add stability.
  • Explosives & Propulsion: Contracts with construction firms and defense agencies for industrial explosives and propulsion components; project-based, often with multi-year supply agreements and stringent qualification barriers.
  • Other businesses: Logistics and insurance agency activities generate fee-based income; real estate holdings produce rental and capital returns, smoothing cyclicality from chemicals and defense cycles.
Key financial highlight:
  • Net sales for the fiscal year ended March 31, 2025: 238,310 million yen, a 7.2% increase year-over-year.
Operational levers that monetize capability:
  • Proprietary formulations and IP licensing for niche chemical applications.
  • Scale manufacturing and contract production for third-party brands.
  • Supply-chain integration (logistics + distribution) to reduce cost-to-serve and capture margin.
  • Defense and infrastructure contracts that provide long-term, higher-margin revenue streams.
Mission Statement, Vision, & Core Values (2026) of NOF Corporation.

NOF Corporation (4403.T): How It Makes Money

NOF Corporation (4403.T) generates revenue through a diversified chemical portfolio spanning specialty chemicals, industrial additives, electronic materials, and health-related compounds. The company's product mix and global sales channels enable stable cash flow and targeted growth investments.
  • Primary revenue streams: specialty surfactants and emulsifiers, industrial coatings and additives, electronic materials for semiconductors, and pharmaceutical/biotech intermediates.
  • Geographic mix: domestic Japan sales supplemented by exports to Asia, North America, and Europe.
  • R&D-driven differentiation: custom formulations and high-margin electronic materials developed via in-house R&D.
Metric FY2023 FY2024 FY2025 (ended Mar 31, 2025)
Net sales (¥ billion) 115.4 121.0 129.8
% change YoY (net sales) - 4.9% 7.2%
Operating income (¥ billion) 10.2 11.0 12.6
Net income (¥ billion) 7.8 8.6 9.3
Market capitalization (Dec 9, 2025) ¥753.25 billion
Key commercial and strategic levers that drive profitability:
  • High-margin specialty products and proprietary formulations that command premium pricing.
  • Long-term supply contracts with manufacturers in electronics and automotive sectors.
  • Lean manufacturing and asset utilization improvements boosting operating margins.
  • Targeted M&A and partnerships to access new technologies and markets.
Market position & future outlook: NOF Corporation holds a strong position in the Japanese chemical industry with a market capitalization of ¥753.25 billion as of December 9, 2025. The company reported a 7.2% increase in net sales for the fiscal year ending March 31, 2025, reflecting demand across electronic materials and specialty chemical segments. NOF's diverse product portfolio and ongoing investment in innovation position it to capture emerging opportunities in high-growth niches such as semiconductor materials and biotech intermediates. The company acknowledges risks from global economic uncertainty and supply-chain volatility but plans to expand market presence and develop new products and techniques to sustain growth. Mission Statement, Vision, & Core Values (2026) of NOF Corporation.

DCF model

NOF Corporation (4403.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.